Multimodal imaging of hallucinogens 25C- and 25I-NBOMe on blotter papers.

@article{Ltzen2019MultimodalIO,
  title={Multimodal imaging of hallucinogens 25C- and 25I-NBOMe on blotter papers.},
  author={Elias L{\"u}tzen and Michael Holtkamp and Imke Stamme and Robin Schmid and Michael Sperling and Michael P{\"u}tz and Uwe Karst},
  journal={Drug testing and analysis},
  year={2019}
}
Due to much lower production costs but similar effects as lysergic acid diethylamide (LSD), phenethylamine derivatives are sold as a cheaper replacement or deceptively as LSD itself. These potent hallucinogenic substances can lead to severe intoxication, thus a more profound understanding of their use is required. This includes the elucidation of the manufacturing processes for the commonly used blotter papers and the assessment of the risk of overdosing because of a heterogeneous distribution… 
5 Citations

Figures and Tables from this paper

Safer Tripping: Serotonergic Psychedelics and Drug Checking. Submission and Detection Rates, Potential Harms, and Challenges for Drug Analysis

Given the substantial proportion of novel SPs in DC samples and the associated risks, DC can be a valuable harm reduction and monitoring tool for SPs if analysis techniques with high sensitivity are employed.

Coupling of Laser Ablation and the Liquid Sampling-Atmospheric Pressure Glow Discharge Plasma for Simultaneous, Comprehensive Mapping: Elemental, Molecular, and Spatial Analysis.

The coupling of an NWR213 laser ablation system to the liquid sampling-atmospheric pressure glow discharge (LS-APGD) microplasma for combined atomic and molecular (CAM) analysis demonstrates a fundamental balance that must be considered between the extent of fragmentation of molecules and ionization of atoms for CAM analysis.

References

SHOWING 1-10 OF 27 REFERENCES

25C-NBOMe--new potent hallucinogenic substance identified on the drug market.

A fatal poisoning involving 25C-NBOMe.

Studies on the metabolism and toxicological detection of the new psychoactive designer drug 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe) in human and rat urine using GC-MS, LC-MSn, and LC-HR-MS/MS

25I-NBOMe was extensively metabolized and could be detected only by the LC-MS screening approaches, demonstrating that drug–drug interactions might occur in certain constellations.

Fatal Intoxications with 25B-NBOMe and 25I-NBOMe in Indiana During 2014.

The deaths of two teenage male subjects that were related to 25B- NBOMe and 25I-NBOMe in Indiana during 2014 are reported and relevant published casework is reviewed.

Two cases of severe intoxication associated with analytically confirmed use of the novel psychoactive substances 25B-NBOMe and 25C-NBOMe

The NBOMe compounds are highly potent 5HT2A receptor agonists and are also agonists at alpha-adrenergic receptors, which likely account for their serotonergic and sympathomimetic symptoms.

Rapid Screening Method for New Psychoactive Substances of Forensic Interest: Electrochemistry and Analytical Determination of Phenethylamines Derivatives (NBOMe) via Cyclic and Differential Pulse Voltammetry.

A novel, fast, and sensitive screening method for the identification of the two most common NBOMes (25B- NBOMe and 25I-NBOMe) in real samples is reported and is selective enough to identify the two compounds individually, even given the great similarity in their structure.

25C-NBOMe and 25I-NBOMe metabolite studies in human hepatocytes, in vivo mouse and human urine with high-resolution mass spectrometry.

The metabolic profile of 25C-NBOMe and 25I- NBOMe was investigated in human hepatocytes, an in vivo mouse model and authentic human urine samples from forensic cases to help clinical and forensic laboratories to develop analytical methods and to interpret results.

25I-NBOMe related death in Australia: a case report.